A phase I trial of idiotypic vaccination with HMFG1 in ovarian cancer

Cancer Immunology Immunotherapy ◽

10.1007/s00262-004-0522-z ◽

2004 ◽

Vol 53 (9) ◽

Author(s):

Steve Nicholson ◽

C.C. Bomphray ◽

H. Thomas ◽

A. McIndoe ◽

D. Barton ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase I ◽

Download Full-text

The PACOVAR-trial: A multicenter phase I trial of pazopanib (GW786034) and metronomic cyclophosphamide in patients with recurrent platinum-resistant ovarian cancer

Geburtshilfe und Frauenheilkunde ◽

10.1055/s-0036-1592664 ◽

2016 ◽

Vol 76 (10) ◽

Author(s):

C Mayer ◽

M Schmidt ◽

EM Grischke ◽

G Gebauer ◽

HC Fricke ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase I ◽

Phase I Trial ◽

Multicenter Phase ◽

Platinum Resistant ◽

Metronomic Cyclophosphamide

Download Full-text

Faculty Opinions recommendation of Phase I trial of a formulated IL-12 plasmid in combination with carboplatin and docetaxel chemotherapy in the treatment of platinum-sensitive recurrent ovarian cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718040504.793483426 ◽

2013 ◽

Author(s):

Roberto Angioli

Keyword(s):

Ovarian Cancer ◽

Phase I ◽

Phase I Trial ◽

Recurrent Ovarian Cancer ◽

Platinum Sensitive ◽

Docetaxel Chemotherapy

Download Full-text

Phase I Trial of Carboplatin, Paclitaxel, Etoposide, and Cyclophosphamide with Granulocyte Colony Stimulating Factor as First-Line Therapy for Patients with Advanced Epithelial Ovarian Cancer

Gynecologic Oncology ◽

10.1006/gyno.2000.5778 ◽

2000 ◽

Vol 77 (2) ◽

pp. 271-277 ◽

Author(s):

Nadine Tung ◽

Ross Berkowitz ◽

Ursula Matulonis ◽

Marc Quartulli ◽

Michael Seiden ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase I ◽

Phase I Trial ◽

Granulocyte Colony Stimulating Factor ◽

Colony Stimulating Factor ◽

First Line Therapy ◽

Line Therapy ◽

Advanced Epithelial Ovarian Cancer ◽

Stimulating Factor

Download Full-text

Phase I trial of a formulated IL-12 plasmid in combination with carboplatin and docetaxel chemotherapy in the treatment of platinum-sensitive recurrent ovarian cancer

Gynecologic Oncology ◽

10.1016/j.ygyno.2013.07.081 ◽

2013 ◽

Vol 131 (1) ◽

pp. 169-173 ◽

Author(s):

Khursheed Anwer ◽

F. Joseph Kelly ◽

Christina Chu ◽

Jason G. Fewell ◽

Danny Lewis ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase I ◽

Phase I Trial ◽

Recurrent Ovarian Cancer ◽

Platinum Sensitive ◽

Docetaxel Chemotherapy

Download Full-text

Phase I Trial of Intraperitoneal Pemetrexed, Cisplatin, and Paclitaxel in Optimally Debulked Ovarian Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-12-0261 ◽

2012 ◽

Vol 18 (9) ◽

pp. 2668-2678 ◽

Author(s):

Setsuko K. Chambers ◽

H-H. Sherry Chow ◽

Mike F. Janicek ◽

Janiel M. Cragun ◽

Kenneth D. Hatch ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase I ◽

Download Full-text

Phase I trial of autologous NK cell immunotherapy combined with chemotherapy in patients with recurrent epithelial ovarian cancer

Gynecologic Oncology ◽

10.1016/j.ygyno.2019.04.618 ◽

2019 ◽

Vol 154 ◽

pp. 266-267

Author(s):

W.D. Joo

Keyword(s):

Ovarian Cancer ◽

Phase I ◽

Epithelial Ovarian Cancer ◽

Phase I Trial ◽

Nk Cell ◽

Cell Immunotherapy

Download Full-text

A Phase I Trial of Dasatinib, an Src-Family Kinase Inhibitor, in Combination with Paclitaxel and Carboplatin in Patients with Advanced or Recurrent Ovarian Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-12-0507 ◽

2012 ◽

Vol 18 (19) ◽

pp. 5489-5498 ◽

Author(s):

Angeles Alvarez Secord ◽

Deanna K. Teoh ◽

William T. Barry ◽

Miao Yu ◽

Gloria Broadwater ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase I ◽

Phase I Trial ◽

Kinase Inhibitor ◽

Recurrent Ovarian Cancer ◽

Src Family Kinase

Download Full-text

Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer

International Journal of Gynecological Cancer ◽

10.1111/j.1525-1438.2006.00466.x ◽

2006 ◽

Vol 16 (2) ◽

pp. 507-514 ◽

Author(s):

C.J. POOLE ◽

T. PERREN ◽

S. GAWANDE ◽

M. RIDDERHEIM ◽

J. COOK ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase I ◽

Drug Administration ◽

Phase I Trial ◽

Recurrent Ovarian Cancer ◽

Download Full-text

Phase I trial of Intraperitoneal (IP) administration of a measles virus (MV) derivative expressing the human carcinoembryonic antigen (CEA) in recurrent ovarian cancer (OvCa)

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.5538 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 5538-5538 ◽

Author(s):

E. Galanis ◽

L. C. Hartmann ◽

W. Cliby ◽

P. P. Peethambaram ◽

H. J. Long ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase I ◽

Carcinoembryonic Antigen ◽

Measles Virus ◽

Phase I Trial ◽

Recurrent Ovarian Cancer

Download Full-text

Phase I trial of cremophor-free, polymeric micelle formulation of paclitaxel with carboplatin in patients with advanced epithelial ovarian cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.e15533 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. e15533-e15533

Author(s):

Y. Kim ◽

S. W. Lee ◽

S. Kim ◽

Y. Kim ◽

B. Kim ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase I ◽

Epithelial Ovarian Cancer ◽

Phase I Trial ◽

Polymeric Micelle ◽

Advanced Epithelial Ovarian Cancer

Download Full-text